The patented technology offers broad freedom to operate and delivers fully human antibodies with high affinity, specificity, expression, solubility ... key platform advantage that ensures drug ...

Insilico then applied its generative chemistry platform for drug discovery ... Optimization of that hit, named ISM001, improved solubility and resulted in good ADME properties.

Only about 4% of candidate drugs reach the market. The main culprits of this failure are due to issues with dosing , exposure and toxicity. Join us as Dr. Paul Leeson shares how improving candidate ...

Zerion Pharma & Aché collaborate to exploit the Dispersome technology for improvement of two marketed drug products: Copenhagen, Denmark Saturday, January 25, 2025, 16:00 Hrs [IS ...

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief ...